Table 4.
Effect of LPS treatment after 1.5 h on metabolite levels among 129Sv mice.
| Metabolites | 129Sv 1.5 h LPS | |||
|---|---|---|---|---|
| Beta (β) | β (95% Cl) | t-value | p-value | |
| Acetylcarnitine (C2) | − | −1.14, −0.54 | −5.93 | < 0.0001 |
| Propionylcarnitine (C3) | −0.87 | −1.14, −0.60 | −6.81 | < 0.0001 |
| Butyryl- and isobutyrylcarnitine (C4-) | −0.85 | −1.14, −0.56 | −6.22 | < 0.0001 |
| Isovalerylcarnitine and 2-methybutyrylcarnitine (C5-) | −0.78 | −1.12, −0.43 | −4.78 | 0.0002 |
| PC aa C42:0 | 0.64 | 0.22, 1.06 | 3.22 | 0.006 |
| SM (OH) C16:1 | 0.56 | 0.11, 1.02 | 2.64 | 0.02 |
Statistically significant regression coefficients (β), confidence intervals (CI) and t- and p values (derived from GLM analysis) of log10-transformed metabolite levels.